1-3 of 3
Neil M. Kogut, MD
Close
Sort by
Journal Articles

Analysis of Predictive Power of Prednisone Dose at 3 Months of Treatment on CGVHD Prognosis.

Pablo M. Parker, MD, Ryotaro Nakamura, MD, Vinod Pullarket, MD, Joseph Rosenthal, MD, Eileen P. Smith, MD, David S. Snyder, MD, Jasmine M. Zain, MD, George Somlo, MD, Annette Brown, Hanjoo Kim, Joycelynne Palmer, PhD, Ji-Lian Cai, MD, Maria L. Delioukina, MD, Peter M. Falk, MD, Chatchada Karanes, MD, Neil M. Kogut, MD, Amrita Krishnan, MD, Auayporn P. Nademanee, MD, Margaret R. O’Donnell, MD, Leslie Popplewell, MD, Firoozeh Sahebi, MD, Ricardo Spielberger, MD, Anthony S. Stein, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2007) 110 (11): 1975.
https://doi.org/10.1182/blood.V110.11.1975.1975
Published: 2007
Journal Articles

Allogeneic Transplant with Standard Conditioning, Reduced Intensity, or Non-Myeloablative Conditioning Regimen for Multiple Myeloma (MM).

Firoozeh Sahebi, MD, Neil M. Kogut, MD, Ricardo Spielberger, MD, Peter M. Falk, MD, Auayporn P. Nademanee, MD, Leslie Popplewell, MD, David G. Maloney, MD, Roberto Rodriguez, MD, Amrita Krishnan, MD, Ryotaro Nakamura, MD, Margaret R. O’Donnell, MD, Parker M. Pablo, MD, Eileen P. Smith, MD, Anthony S. Stein, MD, David S. Snyder, M.D, Jasmine M. Zain, MD, Dajun Qian, Ph.D, Stephen J. Forman, MD, George Somlo, MD
Journal: Blood
Blood (2005) 106 (11): 5427.
https://doi.org/10.1182/blood.V106.11.5427.5427
Published: 2005
Journal Articles

Autologous vs Allogeneic Cell Transplantation for Mantle Cell Lymphoma (MCL): Outcomes over a 10-Year Period at City of Hope.

Leslie L. Popplewell, MD, A. Nademanee, MD, Nora Carter, Jasmine Zain, MD, Amrita Krishnan, MD, Roberto Rodriguez, MD, Neil M. Kogut, MD, Nayana Vora, MD, Arturo Molina, MD, Stephen J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 894.
https://doi.org/10.1182/blood.V104.11.894.894
Published: 2004